Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.
about
Nestin as a marker of cancer stem cellsDrugs derived from phage display: from candidate identification to clinical practicePeptides as targeting probes against tumor vasculature for diagnosis and drug deliverySelection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptinNovel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitroNovel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitroTumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of LactaptinA highly scalable peptide-based assay system for proteomicsHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Combinatorial peptide libraries: mining for cell-binding peptides.Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivoPeptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarrayA novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75(NTR.).Identification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressureFrom phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarkerTargeted delivery of siRNA into breast cancer cells via phage fusion proteins.Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.A novel peptide specifically targeting ovarian cancer identified by in vivo phage display.Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence mattersNovel p16 binding peptide development for p16-overexpressing cancer cell detection using phage display.Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis.Advances in phage display technology for drug discovery.α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer.Advancement and applications of peptide phage display technology in biomedical scienceAdvance in phage display technology for bioanalysis.Phage Peptide Libraries As a Source of Targeted Ligands.A potential peptide vector that allows targeted delivery of a desired fusion protein into the human breast cancer cell line MDA-MB-231.Cell-targeting aptamers act as intracellular delivery vehicles.Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.Near-Infrared Light and pH Dual-Responsive Targeted Drug Carrier Based on Core-Crosslinked Polyaniline Nanoparticles for Intracellular Delivery of Cisplatin.Targeted delivery of paclitaxel to EphA2-expressing cancer cellsSerum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).Multifunctional SPIO/DOX-loaded A54 Homing Peptide Functionalized Dextran-g-PLGA Micelles for Tumor Therapy and MR Imaging.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.Microfluidics in the selection of affinity reagents for the detection of cancer: paving a way towards future diagnostics.Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.Enhanced binding to and killing of hepatocellular carcinoma cells in vitro by melittin when linked with a novel targeting peptide screened from phage display.
P2860
Q26851514-A852CF29-FC5C-462B-943F-C64E49554262Q27007101-08EC1DBD-D962-455C-9791-7DCBB9A31C2BQ27024850-FE9082E1-FFA4-46D8-9794-6B445D4DA078Q28468368-B96BE5C7-4BCD-447A-8473-FDD26E860C9FQ28476756-E5150D65-FF9A-4E2F-92DA-F9BF965AA57DQ28481099-3CEB8EFD-8484-4CA8-BEC9-503D9368A6F0Q28553463-DAB3C503-F5C2-44EC-A4F9-01B197C8B9F7Q28728598-81ED7062-FA71-4490-8793-91219AE0F2C9Q30275493-5183C259-27DF-4150-A1C2-91A376312A56Q31144876-7A0D696C-52C1-460E-B1DD-DA9E49E4231FQ33769196-BB68F6E8-3C90-43C0-BC0E-DBFD7D11DDD4Q33964836-97AB3FCC-E626-4723-AC49-0504458F1E6DQ34039390-B01EC719-9777-42AA-9CA9-2DBB5C5401A0Q34212777-A6EA9224-9E91-47C7-A953-4A3283EB1ED2Q34343508-C1660B33-0898-4500-8064-011CFE9AB107Q34491680-E735A103-2F7B-4FCA-8933-138967D84D8FQ34501858-F4D4C210-28DB-417C-9048-19C8C8C813CDQ35011982-016DEC5B-D51F-4B00-ADCA-E2A2F21A5B5CQ35012239-7257B33F-B508-4EE1-8ED4-B1C64E9AC2F2Q35131992-9CAB90DC-6BE2-4143-94AB-CBF3A348B420Q35256650-03568032-CFF5-45C8-BF87-B5CDA7C56734Q35574209-B9E8FDEE-48D9-4880-997A-9A9C3FF9260CQ35604249-02D9A56B-A76E-4CD1-A34F-6FE3F684FD21Q35614190-FE52A8BE-8941-4C16-A10F-B2E66E150FF9Q35652276-3BB6C750-C44C-41A4-84B2-51A47775DBD6Q35898339-05A28958-AB98-4990-A265-E7B060520652Q35984472-26BD25D1-47A4-44EC-B538-892D48EB648FQ35995567-7F384F11-D5DC-4C78-8077-6446BE31A309Q36055183-D879EB76-D0FC-466D-9AD5-E43A39BDAF46Q36062913-AE48EB66-1991-49B3-B535-EAFCBB3068D4Q36139002-2F5072B7-A9F9-4D03-AED9-86818CA6C3B8Q36278231-C0CC4A0B-C6B8-499D-A9CE-1A45BBC22DA4Q36511070-5868A7AC-E3C9-463C-AE01-7B9B6A11CC9BQ37045947-DFE76A7F-67E3-44E6-AFAB-08EA2FDFC08CQ37360440-DCCC0E48-CDDC-45DB-95C8-8E6093640F57Q37422972-DFB4D352-113C-4466-9759-9EA9F89D2497Q37885883-131E78EB-6234-4FAC-B6E3-703429EF431AQ38844919-681751B6-B415-4A59-9913-FE28F55B4C99Q38910806-36F3979F-5743-457F-AC87-335EF8E29572Q39098507-6B5A296F-D8BE-4298-B19A-4EAB4CD4FC1D
P2860
Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Peptidic tumor targeting agent ...... ions to clinical applications.
@ast
Peptidic tumor targeting agent ...... ions to clinical applications.
@en
Peptidic tumor targeting agent ...... ions to clinical applications.
@nl
type
label
Peptidic tumor targeting agent ...... ions to clinical applications.
@ast
Peptidic tumor targeting agent ...... ions to clinical applications.
@en
Peptidic tumor targeting agent ...... ions to clinical applications.
@nl
prefLabel
Peptidic tumor targeting agent ...... ions to clinical applications.
@ast
Peptidic tumor targeting agent ...... ions to clinical applications.
@en
Peptidic tumor targeting agent ...... ions to clinical applications.
@nl
P2860
P1476
Peptidic tumor targeting agent ...... ions to clinical applications.
@en
P2093
Kathlynn C Brown
P2860
P304
P356
10.2174/138161210790963788
P577
2010-01-01T00:00:00Z